🇺🇸 FDA
Pipeline program

INT230-6

IT-03

Phase 3 small_molecule active

Quick answer

INT230-6 for Sarcoma,Soft Tissue is a Phase 3 program (small_molecule) at INTENSITY THERAPEUTICS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INTENSITY THERAPEUTICS, INC.
Indication
Sarcoma,Soft Tissue
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials